Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersGynecologic Oncology Physician in Camden, NJ
NPI: 1326144940Primary Practice Location
COOPER UNIVERSITY HOSPITAL
1 Cooper Plz, Camden, NJ
Primary Employer
Redeemer Cancer Care Physicians Network, LLC
redeemerhealth.org
HQ Phone
Get M.D. David's Phone Numberphone_androidMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
NJ State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 60 | 77 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 51 | 51 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 47 | 61 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 35 | 40 |
| 5 | 58571Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | 26 | 26 |
Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study.
Authors: Albert Bonebrake, Lainie Martin, Stephen Rose, Lisa Landrum, Lois Ramondetta
Publication Date: 2012-07-20
Authors: Nitika Thawani, Summer Dewdney, Jayanthi Lea, Bradley Monk, Floortje Backes, Mario Leitao, Ahmed Elsayed, Paul Disilvestro, Ivy Wilkinson-Ryan, Mark Shahin
Journal: Gynecol Oncol
Publication Date: 2025-03-07
Lead Sponsor: Imunon
Intervention / Treatment: DRUG: Carboplatin, DRUG: Paclitaxel, BIOLOGICAL: IMNN-001
Lead Sponsor: Agenus Inc.
Collaborators: GOG Foundation
Intervention / Treatment: DRUG: AGEN2034, DRUG: AGEN1884
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, RADIATION: External Beam Radiation Therapy, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, PROCEDURE: X-Ray Imaging, RADIATION: Brachytherapy
